Sabra Reports Third Quarter 2019 Results; Continues to Improve Leverage and Other Credit Metrics; Reaffirms 2019 Guidance

Go back to Sabra Reports Third Quarter 2019 Results; Continues to Improve Leverage and Other Credit Metrics; Reaffirms 2019 Guidance

Sabra Health Care REIT (SBRA) Misses Q3 EPS by 5c

October 30, 2019 5:47 PM EDT

Sabra Health Care REIT (NASDAQ: SBRA) reported Q3 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $149.83 million versus the consensus estimate of $149.39 million.

Commenting on the third quarter results, Rick Matros, CEO and Chairman, said, We continued to execute our strategy and make meaningful improvements to our balance sheet... More